The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the ...
In a new Truth Social post Friday morning, President Donald Trump suggested that former President Joe Biden and other former ...
Oz, President Donald Trump's pick to lead the Centers for Medicare and Medicaid Services, will testify before the Senate ...
Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...
A draconian federal policy enforces a lifetime of punishment by denying Fair Housing protections to individuals convicted of drug distribution.
A veteran of the semiconductor industry, Lip-Bu Tan has an even longer track record as a technology investor, particularly in ...
Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...
The U.S. Food and Drug Administration's chief counsel, Hilary Perkins, has resigned, the federal agency said in a post on ...
Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...
Here is why Lip-Bu Tan’s appointment to Intel’s top job makes sense in the prevailing circumstances.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results